A menopause society recommends CBT for hot flushes — but for how bad they feel

Cognitive behavioural therapy is one of the few non-hormone treatments for menopausal hot flushes that the North American Menopause Society recommends at its highest level of evidence, putting a talking therapy alongside prescription drugs as a genuine option [s1]. But it is important to be clear about what CBT does: the trial evidence shows it reduces how much hot flushes and night sweats bother women, more than it reduces the physiological event itself [s2].

What the guidance recommends

The Menopause Society's 2023 non-hormone position statement reviewed the evidence for lifestyle measures, mind–body techniques, prescription drugs, supplements and other approaches, grading each by evidence quality [s1]. The treatments it recommends at Level I — good and consistent scientific evidence — are cognitive behavioural therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin and fezolinetant; oxybutynin is recommended at Levels I–II, and weight loss and stellate ganglion block at Levels II–III [s1].

Just as informative is the list it does not recommend, which includes several popular measures: paced respiration (Level I evidence against benefit), supplements and herbal remedies (Levels I–II), and — at Level II — cooling techniques, trigger avoidance, exercise, yoga, mindfulness-based intervention, relaxation, soy foods and soy extracts, cannabinoids and acupuncture [s1]. Several of these are the first things women are told to try. The statement is blunt that hormone therapy remains the most effective treatment for vasomotor symptoms and should be considered in women within 10 years of their final menstrual period; CBT's place is as an evidence-backed option for those who cannot or prefer not to take it [s1].

The trial behind the recommendation

The clearest test of CBT for this purpose is MENOS 2, a randomised controlled trial of 140 women who were having 10 or more problematic hot flushes or night sweats a week for at least a month [s2]. Participants were assigned to group CBT, guided self-help CBT, or no treatment. The primary outcome was the "problem rating" of hot flushes and night sweats — how much they bothered the woman, scored from 1 to 10 — at six weeks [s2]. At baseline the women were having a mean of 63.15 flushes or sweats a week, with a mean problem rating of 5.87 [s2].

Both formats worked. Against the no-treatment control, group CBT cut the problem rating by an adjusted mean of 2.12 points (95% CI, 1.36 to 2.88; P < 0.001) and guided self-help CBT by 2.08 points (95% CI, 1.29 to 2.86; P < 0.001) at six weeks [s2]. The effect held, though it shrank, at 26 weeks: 1.33 points for group CBT (95% CI, 0.54 to 2.13; P = 0.001) and 1.19 points for self-help (95% CI, 0.36 to 2.02; P = 0.005) [s2]. The trial also recorded reductions in night-sweat frequency and improvements in mood and quality of life [s2].

The distinction that matters

The outcome CBT moves most is the problem rating, not the number of flushes a body produces. That is not a weakness hidden in the data — it is the mechanism. CBT for vasomotor symptoms works on the appraisal of and reaction to a flush: the beliefs, the anticipatory anxiety, the disrupted sleep and the sense of loss of control that turn a physiological event into a distressing one. A woman may still flush, but flush less bothered by it. That reframes what "effective" means here, and it is exactly the kind of thing that gets flattened when CBT is marketed as a way to "stop hot flushes." It does not switch off the thermostat; it changes how loudly the alarm rings.

That framing also explains why CBT sits so differently from the options the same statement rejects. This is not another entry in the long list of gentle-sounding remedies that fail on testing — it cleared Level I evidence precisely because trials measured a real, patient-reported outcome and found a consistent effect [s1][s2].

What it means for a reader

For a woman weighing non-hormone options, CBT is among the small number with good evidence behind it, delivered in a group or as guided self-help, and it carries none of the drug interactions or contraindications that complicate the prescription alternatives [s1]. It sits alongside the evidence Health Newspapers has assembled on what complementary therapies for menopause actually deliver, the full range of non-vasomotor symptoms women report, and the newer non-hormonal drugs targeting the flush directly. What CBT does not do is replace hormone therapy for women who want the largest reduction in flushing and have no reason to avoid it [s1]. This article is informational and is not medical advice.

What to watch

Whether access catches up with evidence. A Level I recommendation is only useful if the therapy can be reached, and menopause-specific CBT — particularly the guided self-help format that worked nearly as well as face-to-face groups in MENOS 2 — is still far easier to recommend than to obtain [s2].

Sources

• The 2023 nonhormone therapy position statement of The North American Menopause Society — Menopause, 2023-06-01
• Effectiveness of group and self-help CBT in reducing problematic menopausal hot flushes and night sweats (MENOS 2) — Menopause, 2012-07-01